Article
Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER- breast cancer: A Mendelian randomization study.
Medicine - 25 Oct 2024
Wu Shang, Ma Xin-Di, Zhang Xiang-Mei, Shi Chao, Du Kai-Ye, Liu Yun-Jiang
Abstract excerpt
This study aims to investigate the connection between 25-hydroxyvitamin D (25(OH)D) levels and the prognosis of breast cancer with various estrogen receptor (ER) statuses. The summary statistics of 25(OH)D levels was obtained from a GWAS of 441,291 individuals and the information of breast cancer was collected from the Breast Cancer Association Consortium. We analyzed the causal association between 25(OH)D levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
